parent_id,parent_name,child_id,child_name,parent_smiles,child_smiles,origin,source
DB00169,Cholecalciferol,DB00136,Calcitriol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,DB00169,DrugBank Augmented
DB00318,Codeine,DB06409,Morphine glucuronide,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,DB00318,DrugBank Augmented
DB15566,Prednisolone acetate,DB00635,Prednisone,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15465,Benzhydrocodone,DB00327,Hydromorphone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,DB15465,DrugBank Augmented
DB09419,Xylose,DB03947,D-Xylulose,O=CC(O)C(O)C(O)CO,O=C(CO)C(O)C(O)CO,DB09419,DrugBank Augmented
DB00169,Cholecalciferol,DB00136,Calcitriol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,DB00169,DrugBank Augmented
DB09419,Xylose,DB03947,D-Xylulose,O=CC(O)C(O)C(O)CO,O=C(CO)C(O)C(O)CO,DB09419,DrugBank Augmented
DB11358,,DB00154,Dihomo-gamma-linolenic acid,,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,DB11358,DrugBank Augmented
DB13854,Gamolenic acid,DB04557,Arachidonic Acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented
DB11358,,DB00154,Dihomo-gamma-linolenic acid,,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,DB11358,DrugBank Augmented
DB13854,Gamolenic acid,DB04557,Arachidonic Acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,DB13854,DrugBank Augmented
DB15465,Benzhydrocodone,DB00327,Hydromorphone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,DB15465,DrugBank Augmented
DB15566,Prednisolone acetate,DB00635,Prednisone,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB00201,Caffeine,DBMET00271,1-Methylxanthine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c2nc[nH]c2c1=O,DB00201,DrugBank Augmented
DB00795,Sulfasalazine,DBMET00924,N-acetyl-5-ASA (Ac-5-ASA),O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,CC(=O)Nc1ccc(O)c(C(=O)O)c1,DB00795,DrugBank Augmented
DB00201,Caffeine,DBMET00271,1-Methylxanthine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c2nc[nH]c2c1=O,DB00201,DrugBank Augmented
DB00451,Levothyroxine,DBMET02273,Diiodothyronine,NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,NC(Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1)C(=O)O,DB00451,DrugBank Augmented
DB00285,Venlafaxine,DBMET00437,"N,O-Didesmethylvenlafaxine",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented
DB00285,Venlafaxine,DBMET00967,O-Desmethylvenlafaxine glucuronide,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,NCC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented
DB00321,Amitriptyline,DBMET00052,E-10-Hydroxynortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CNCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented
DB00321,Amitriptyline,DBMET00053,Desmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CCc2ccccc21,DB00321,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET00866,Hydromorphone-3-glucuronide,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(=O)CCC3C1C5,DB15465,DrugBank Augmented
DB13783,Acemetacin,DBMET00157,Indomethacin acyl glucuronide,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,COc1ccc2c(c1)c(CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)c(C)n2C(=O)c1ccc(Cl)cc1,DB13783,DrugBank Augmented
DB00451,Levothyroxine,DBMET02273,Diiodothyronine,NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,NC(Cc1cc(I)c(Oc2ccc(O)cc2)c(I)c1)C(=O)O,DB00451,DrugBank Augmented
DB00514,Dextromethorphan,DBMET01318,3-Hydroxymorphinan,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,Oc1ccc2c(c1)C13CCCCC1C(C2)NCC3,DB00514,DrugBank Augmented
DB00321,Amitriptyline,DBMET00053,Desmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CCc2ccccc21,DB00321,DrugBank Augmented
DB01420,Testosterone propionate,DBMET01762,2alpha-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET01763,2beta-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET01764,15alpha-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET01765,15beta-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET01766,16alpha-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET01767,16beta-hydroxytestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00571,5-alpha-Dihydrotestosterone glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02830,5-alpha androstanedione,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02859,"17α,21-dihydroxy-pregnan-1,4,6-trien-3,11,30-trione (M-XVII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02860,20α-dihydro-prednisone (M-V),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02861,20β-dihydro-prednisone (M-IV),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02863,6α-hydroxy-prednisone (M-XIII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02864,6βhydroxy-prednisone (M-XII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB00755,Tretinoin,DBMET03635,13-cis-4-Oxoretinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00755,Tretinoin,DBMET03638,9-cis-4-Oxoretinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00332,Ipratropium,DBMET01954,4-hydroxyphenylacetic acid,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,O=C(O)Cc1ccc(O)cc1,DB00332,DrugBank Augmented
DB00332,Ipratropium,DBMET01954,4-hydroxyphenylacetic acid,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,O=C(O)Cc1ccc(O)cc1,DB00332,DrugBank Augmented
DB13952,Estradiol acetate,DBMET00572,17-beta-Estradiol-3-glucuronide,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4ccc(OC5OC(C(=O)O)C(O)C(O)C5O)cc4CCC3C1CCC2O,DB13952,DrugBank Augmented
DB13952,Estradiol acetate,DBMET00583,17-alpha-Estradiol-3-glucuronide,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4ccc(OC5OC(C(=O)O)C(O)C(O)C5O)cc4CCC3C1CCC2O,DB13952,DrugBank Augmented
DB13952,Estradiol acetate,DBMET00600,Estradiol-17alpha 3-D-glucuronoside,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4ccc(OC5OC(C(=O)O)C(O)C(O)C5O)cc4CCC3C1CCC2O,DB13952,DrugBank Augmented
DB13952,Estradiol acetate,DBMET00248,2-hydroxyestrone,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4cc(O)c(O)cc4CCC3C1CCC2=O,DB13952,DrugBank Augmented
DB13952,Estradiol acetate,DBMET01658,4-Hydroxyestradiol,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4ccc(O)c(O)c4CCC3C1CCC2O,DB13952,DrugBank Augmented
DB13952,Estradiol acetate,DBMET00248,,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4cc(O)c(O)cc4CCC3C1CCC2=O,DB13952,DrugBank Augmented
DB00795,Sulfasalazine,DBMET00924,N-acetyl-5-ASA (Ac-5-ASA),O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,CC(=O)Nc1ccc(O)c(C(=O)O)c1,DB00795,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02848,Δ6-prednisolone (M-XI),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02849,20α-dihydro-prednisolone (M-III),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02850,20β-dihydro-prednisolone (M-II),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02851,6αhydroxy-prednisolone (M-VII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02853,6βhydroxy-prednisolone(M-VI),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02859,"17α,21-dihydroxy-pregnan-1,4,6-trien-3,11,30-trione (M-XVII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02860,20α-dihydro-prednisone (M-V),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02861,20β-dihydro-prednisone (M-IV),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02863,6α-hydroxy-prednisone (M-XIII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02864,6βhydroxy-prednisone (M-XII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB01408,Bambuterol,DBMET03275,Terbutaline Sulfate,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,DB01408,DrugBank Augmented
DB01408,Bambuterol,DBMET03276,Terbutaline Glucuronide,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,DB01408,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET00420,norhydrocodone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(=O)CCC4C(C2)NCCC314,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02686,6-α-hydrocodol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02687,6-β-hydrocodol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02685,6-α-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02684,6-β-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02723,Hydromorphone glucuronide conjugate,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(=O)CCC3C1C5,DB15465,DrugBank Augmented
DB00755,Tretinoin,DBMET02554,4-hydroxy-13-cis-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET00087,Diphenhydramine N-glucuronide,Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,C[N+](C)(CCOC(c1ccccc1)c1ccccc1)C1OC(C(=O)O)C(O)C(O)C1O,DB00985,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET00086,N-Desmethyldiphenhydramine,Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,CNCCOC(c1ccccc1)c1ccccc1,DB00985,DrugBank Augmented
DB01235,Levodopa,DBMET00565,Dopamine 4-sulfate,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(OS(=O)(=O)O)c(O)c1,DB01235,DrugBank Augmented
DB01235,Levodopa,DBMET00573,Dopamine 3-O-sulfate,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(O)c(OS(=O)(=O)O)c1,DB01235,DrugBank Augmented
DB01235,Levodopa,DBMET00587,Dopamine glucuronide,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(O)c1,DB01235,DrugBank Augmented
DB16627,Melphalan flufenamide,DBMET03698,Monohydroxymelphalan,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1,NC(Cc1ccc(N(CCO)CCCl)cc1)C(=O)O,DB16627,DrugBank Augmented
DB16627,Melphalan flufenamide,DBMET03699,,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1,NC(Cc1ccc(N(CCO)CCO)cc1)C(=O)O,DB16627,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET00086,N-Desmethyldiphenhydramine,Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,CNCCOC(c1ccccc1)c1ccccc1,DB00985,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET00087,Diphenhydramine N-glucuronide,Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,C[N+](C)(CCOC(c1ccccc1)c1ccccc1)C1OC(C(=O)O)C(O)C(O)C1O,DB00985,DrugBank Augmented
DB01086,Benzocaine,DBMET03290,4-Acetaminobenzoic acid,CCOC(=O)c1ccc(N)cc1,CC(=O)Nc1ccc(C(=O)O)cc1,DB01086,DrugBank Augmented
DB12902,Trofosfamide,DBMET00021,3-Dechloroethylifosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=P1(NCCCl)NCCCO1,DB12902,DrugBank Augmented
DB12902,Trofosfamide,DBMET00022,Dechloroethylifosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,NP1(=O)OCCCN1CCCl,DB12902,DrugBank Augmented
DB12902,Trofosfamide,DBMET00023,Chloroacetaldehyde,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=CCCl,DB12902,DrugBank Augmented
DB12902,Trofosfamide,DBMET00024,4-Hydroxyifosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=P1(NCCCl)OCCC(O)N1CCCl,DB12902,DrugBank Augmented
DB01235,Levodopa,DBMET02448,Dopamine-3-O-sulfate,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(O)c(OS(=O)(=O)O)c1,DB01235,DrugBank Augmented
DB01235,Levodopa,DBMET02449,Dopamine-4-O-sulfate,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(OS(=O)(=O)O)c(O)c1,DB01235,DrugBank Augmented
DB01235,Levodopa,DBMET02450,Dopamine-4-O-glucuronide,NC(Cc1ccc(O)c(O)c1)C(=O)O,NCCc1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(O)c1,DB01235,DrugBank Augmented
DB00795,Sulfasalazine,DBMET03621,N-acetyl-5-aminosalicylic acid,O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,CC(=O)Nc1ccc(O)c(C(=O)O)c1,DB00795,DrugBank Augmented
DB01255,Lisdexamfetamine,DBMET03721,4-Hydroxy-d-amphetamine,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(N)Cc1ccc(O)cc1,DB01255,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01255,Lisdexamfetamine,DBMET00733,4-hydroxyamphetamine,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(N)Cc1ccc(O)cc1,DB01255,DrugBank Augmented
DB00285,Venlafaxine,DBMET00437,"N,O-Didesmethylvenlafaxine",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented
DB16629,Serdexmethylphenidate,DBMET02407,p-hydroxy-methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(=O)C(c1ccc(O)cc1)C1CCCCN1,DB16629,DrugBank Augmented
DB16629,Serdexmethylphenidate,DBMET02408,6-oxo-methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(=O)C(c1ccccc1)C1CCCC(=O)N1,DB16629,DrugBank Augmented
DB16629,Serdexmethylphenidate,DBMET00651,Ritalinic acid,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,O=C(O)C(c1ccccc1)C1CCCCN1,DB16629,DrugBank Augmented
DB07565,Chloramphenicol succinate,DBMET03162,Chloramphenicol Oxamic Acid,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(O)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented
DB08804,Nandrolone decanoate,DBMET03358,19-Norandrosterone,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,DB08804,DrugBank Augmented
DB08804,Nandrolone decanoate,DBMET03360,19-Norepiandrosterone,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,DB08804,DrugBank Augmented
DB09042,Tedizolid phosphate,DBMET03127,Ring-opened tedizolid metabolite,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,Cn1nnc(-c2ccc(-c3ccc(NCC(=O)O)cc3F)cn2)n1,DB09042,DrugBank Augmented
DB09419,Xylose,DBMET02033,D-Xylulose-5-phosphate,O=CC(O)C(O)C(O)CO,O=C(CO)C(O)C(O)COP(=O)(O)O,DB09419,DrugBank Augmented
DB09419,Xylose,DBMET02033,D-Xylulose-5-phosphate,O=CC(O)C(O)C(O)CO,O=C(CO)C(O)C(O)COP(=O)(O)O,DB09419,DrugBank Augmented
DB11358,,DBMET02087,15-HETrE,,CCCCCC(O)C=CC=CCC=CCCCCCCC(=O)O,DB11358,DrugBank Augmented
DB11358,,DBMET02086,Prostaglandin E1,,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,DB11358,DrugBank Augmented
DB11358,,DBMET02087,15-HETrE,,CCCCCC(O)C=CC=CCC=CCCCCCCC(=O)O,DB11358,DrugBank Augmented
DB11358,,DBMET02086,Prostaglandin E1,,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,DB11358,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET00420,norhydrocodone,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(=O)CCC4C(C2)NCCC314,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02686,6-α-hydrocodol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02687,6-β-hydrocodol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02685,6-α-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02684,6-β-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02848,Δ6-prednisolone (M-XI),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02849,20α-dihydro-prednisolone (M-III),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02850,20β-dihydro-prednisolone (M-II),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02851,6αhydroxy-prednisolone (M-VII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02853,6βhydroxy-prednisolone(M-VI),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02859,"17α,21-dihydroxy-pregnan-1,4,6-trien-3,11,30-trione (M-XVII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C=CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02860,20α-dihydro-prednisone (M-V),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02861,20β-dihydro-prednisone (M-IV),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02863,6α-hydroxy-prednisone (M-XIII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02864,6βhydroxy-prednisone (M-XII),CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB16627,Melphalan flufenamide,DBMET03273,Monohydroxy-melphalan,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1,NC(Cc1ccc(N(CCO)CCCl)cc1)C(=O)O,DB16627,DrugBank Augmented
DB16627,Melphalan flufenamide,DBMET03274,Dihydroxy-melphalan,CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1,NC(Cc1ccc(N(CCO)CCO)cc1)C(=O)O,DB16627,DrugBank Augmented
DB16629,Serdexmethylphenidate,DBMET00651,Ritalinic acid,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,O=C(O)C(c1ccccc1)C1CCCCN1,DB16629,DrugBank Augmented
DB16629,Serdexmethylphenidate,DBMET02408,6-oxo-methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(=O)C(c1ccccc1)C1CCCC(=O)N1,DB16629,DrugBank Augmented
DB16629,Serdexmethylphenidate,DBMET02407,p-hydroxy-methylphenidate,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(=O)C(c1ccc(O)cc1)C1CCCCN1,DB16629,DrugBank Augmented
DB11635,,DBMET02311,13'-carboxy-alpha-tocopherol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C(=O)O)O2,DB11635,DrugBank Augmented
DB01255,Lisdexamfetamine,DBMET01018,4-Hydroxynorephedrine,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(N)C(O)c1ccc(O)cc1,DB01255,DrugBank Augmented
DB00188,Bortezomib,DBMET01063,Bortezomib metabolite M3,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01063,Bortezomib metabolite M3,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01065,Bortezomib metabolite M5,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,CC(C)(O)CC(O)NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01066,Bortezomib metabolite M6,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,CC(C)(O)CC(O)NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01082,Bortezomib metabolite M25,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,CC(C)C(O)C(O)NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01084,Bortezomib metabolite M26,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,CC(C)C(O)C(O)NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01085,Bortezomib metabolite M27,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,CC(C)C(O)C(O)NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00188,Bortezomib,DBMET01086,Bortezomib metabolite M28,CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,CC(C)C(O)C(O)NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1,DB00188,DrugBank Augmented
DB00193,Tramadol,DBMET00957,"N,O-didesmethyltramadol",COc1cccc(C2(O)CCCCC2CN(C)C)c1,CNCC1CCCCC1(O)c1cccc(O)c1,DB00193,DrugBank Augmented
DB00193,Tramadol,DBMET00957,"N,O-didesmethyltramadol",COc1cccc(C2(O)CCCCC2CN(C)C)c1,CNCC1CCCCC1(O)c1cccc(O)c1,DB00193,DrugBank Augmented
DB00201,Caffeine,DBMET00271,1-Methylxanthine,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cn1c(=O)[nH]c2nc[nH]c2c1=O,DB00201,DrugBank Augmented
DB00215,Citalopram,DBMET03705,didemethylcitalopram,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCCN)c1ccc(F)cc1,DB00215,DrugBank Augmented
DB00215,Citalopram,DBMET03706,Citalopram propionic aldehyde,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC=O)c1ccc(F)cc1,DB00215,DrugBank Augmented
DB00215,Citalopram,DBMET03707,Citalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB00215,DrugBank Augmented
DB00215,Citalopram,DBMET03707,Citalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB00215,DrugBank Augmented
DB00215,Citalopram,DBMET03707,Citalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB00215,DrugBank Augmented
DB00281,Lidocaine,DBMET01090,3-Hydroxymonoethylglycinexylidide,CCN(CC)CC(=O)Nc1c(C)cccc1C,CCNCC(=O)Nc1c(C)ccc(O)c1C,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01090,3-Hydroxymonoethylglycinexylidide,CCN(CC)CC(=O)Nc1c(C)cccc1C,CCNCC(=O)Nc1c(C)ccc(O)c1C,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01089,"2,6-Dimethylaniline (2,6-Xylidine)",CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C)c1N,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01091,Glycinexylidide (GX),CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C)c1NC(=O)CN,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01128,2-Amino-3-methylbenzoate,CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C(=O)O)c1N,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01129,"4-Hydroxy-2,6-dimethylaniline",CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cc(O)cc(C)c1N,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01128,2-Amino-3-methylbenzoate,CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C(=O)O)c1N,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01128,2-Amino-3-methylbenzoate,CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C(=O)O)c1N,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01129,"4-Hydroxy-2,6-dimethylaniline",CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cc(O)cc(C)c1N,DB00281,DrugBank Augmented
DB00281,Lidocaine,DBMET01129,"4-Hydroxy-2,6-dimethylaniline",CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cc(O)cc(C)c1N,DB00281,DrugBank Augmented
DB00285,Venlafaxine,DBMET00437,"N,O-Didesmethylvenlafaxine",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented
DB00285,Venlafaxine,DBMET00958,"N,O-didesmethylvenlafaxine glucuronide",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented
DB00296,Ropivacaine,DBMET03534,4-OH-PPX,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Cc1cc(O)cc(C)c1NC(=O)C1CCCCN1,DB00296,DrugBank Augmented
DB00296,Ropivacaine,DBMET03535,3-OH-PPX,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Cc1ccc(O)c(C)c1NC(=O)C1CCCCN1,DB00296,DrugBank Augmented
DB00296,Ropivacaine,DBMET03534,4-OH-PPX,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Cc1cc(O)cc(C)c1NC(=O)C1CCCCN1,DB00296,DrugBank Augmented
DB00296,Ropivacaine,DBMET03535,3-OH-PPX,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,Cc1ccc(O)c(C)c1NC(=O)C1CCCCN1,DB00296,DrugBank Augmented
DB00300,Tenofovir disoproxil,DBMET01177,Tenofovir Diphosphate,CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C,CC(Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,DB00300,DrugBank Augmented
DB00313,Valproic acid,DBMET01110,3-Oxovalproic acid,CCCC(CCC)C(=O)O,CCCC(C(=O)O)C(=O)CC,DB00313,DrugBank Augmented
DB00313,Valproic acid,DBMET01110,3-Oxovalproic acid,CCCC(CCC)C(=O)O,CCCC(C(=O)O)C(=O)CC,DB00313,DrugBank Augmented
DB00321,Amitriptyline,DBMET00052,E-10-Hydroxynortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CNCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented
DB00321,Amitriptyline,DBMET00482,E-10-Hydroxydesmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented
DB00321,Amitriptyline,DBMET00482,E-10-Hydroxydesmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented
DB00349,Clobazam,DBMET03601,4'-hydroxy-N-desmethylclobazam,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,O=C1CC(=O)N(c2ccc(O)cc2)c2cc(Cl)ccc2N1,DB00349,DrugBank Augmented
DB00349,Clobazam,DBMET03601,4'-hydroxy-N-desmethylclobazam,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,O=C1CC(=O)N(c2ccc(O)cc2)c2cc(Cl)ccc2N1,DB00349,DrugBank Augmented
DB00352,Tioguanine,DBMET01153,Methyl-thioguanosine monophosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,CSC1N=C(N)Nc2c1ncn2C1OC(COP(=O)(O)O)C(O)C1O,DB00352,DrugBank Augmented
DB00352,Tioguanine,DBMET01154,Thioguanosine diphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3OC(COP(=O)(O)OP(=O)(O)O)C(O)C3O)c2[nH]1,DB00352,DrugBank Augmented
DB00394,Beclomethasone dipropionate,DBMET02591,Beclomethasone (BOH),CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO,DB00394,DrugBank Augmented
DB00394,Beclomethasone dipropionate,DBMET02591,Beclomethasone (BOH),CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO,DB00394,DrugBank Augmented
DB00404,Alprazolam,DBMET02467,"alpha,4-dihydroxy-alprazolam",Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2O,DB00404,DrugBank Augmented
DB00404,Alprazolam,DBMET02467,"alpha,4-dihydroxy-alprazolam",Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,OCc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2O,DB00404,DrugBank Augmented
DB00409,Remoxipride,DBMET03194,Remoxipride Metabolite NCL 118,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1CCC(=O)N1,DB00409,DrugBank Augmented
DB00409,Remoxipride,DBMET03194,Remoxipride Metabolite NCL 118,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1CCC(=O)N1,DB00409,DrugBank Augmented
DB00412,Rosiglitazone,DBMET00936,N-Desmethyl-ortho-hydroxy rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ncccc3O)cc2)S1,DB00412,DrugBank Augmented
DB00412,Rosiglitazone,DBMET00936,N-Desmethyl-ortho-hydroxy rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ncccc3O)cc2)S1,DB00412,DrugBank Augmented
DB00412,Rosiglitazone,DBMET00938,N-Desmethyl-para-hydroxy rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ccc(O)cn3)cc2)S1,DB00412,DrugBank Augmented
DB00412,Rosiglitazone,DBMET00938,N-Desmethyl-para-hydroxy rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,O=C1NC(=O)C(Cc2ccc(OCCNc3ccc(O)cn3)cc2)S1,DB00412,DrugBank Augmented
DB01151,Desipramine,DBMET01956,2-hydroxydesipramine glucuronide,CNCCCN1c2ccccc2CCc2ccccc21,CNCCCN1c2ccccc2CCc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc21,DB01151,DrugBank Augmented
DB00461,Nabumetone,DBMET02537,4-(6-hydroxy-2-naphthyl)- butan-2-ol,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02537,4-(6-hydroxy-2-naphthyl)- butan-2-ol,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented
DB00470,Dronabinol,DBMET01220,"8,11-Dihydroxy-delta-9-THC",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CC(O)C(CO)=CC21,DB00470,DrugBank Augmented
DB00470,Dronabinol,DBMET01220,"8,11-Dihydroxy-delta-9-THC",CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CC(O)C(CO)=CC21,DB00470,DrugBank Augmented
DB00476,Duloxetine,DBMET02506,Catechol duloxetine,CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(O)c(O)ccc12)c1cccs1,DB00476,DrugBank Augmented
DB00476,Duloxetine,DBMET02506,Catechol duloxetine,CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(O)c(O)ccc12)c1cccs1,DB00476,DrugBank Augmented
DB00497,Oxycodone,DBMET02514,alpha-oxymorphol,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3(O)C1C5,DB00497,DrugBank Augmented
DB00497,Oxycodone,DBMET00427,beta-oxymorphol,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3(O)C1C5,DB00497,DrugBank Augmented
DB00497,Oxycodone,DBMET00424,noroxymorphone,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3)C1O5,DB00497,DrugBank Augmented
DB00497,Oxycodone,DBMET00425,alpha-noroxycodol,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4(O)C(C2)NCCC314,DB00497,DrugBank Augmented
DB00497,Oxycodone,DBMET00426,beta-noroxycodol,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,COc1ccc2c3c1OC1C(O)CCC4(O)C(C2)NCCC314,DB00497,DrugBank Augmented
DB00497,Oxycodone,DBMET00424,noroxymorphone,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3)C1O5,DB00497,DrugBank Augmented
DB00502,Haloperidol,DBMET01212,Haloperidol pyridinium ion derivative,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)c1ccc(F)cc1,DB00502,DrugBank Augmented
DB00514,Dextromethorphan,DBMET01318,3-Hydroxymorphinan,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,Oc1ccc2c(c1)C13CCCCC1C(C2)NCC3,DB00514,DrugBank Augmented
DB00533,Rofecoxib,DBMET01292,cis-Dihydrorofecoxib,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,CS(=O)(=O)c1ccc(C2COC(=O)C2c2ccccc2)cc1,DB00533,DrugBank Augmented
DB00533,Rofecoxib,DBMET01293,trans-Dihydrorofecoxib,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,CS(=O)(=O)c1ccc(C2COC(=O)C2c2ccccc2)cc1,DB00533,DrugBank Augmented
DB00321,Amitriptyline,DBMET00482,E-10-Hydroxydesmethylnortriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCCC=C1c2ccccc2CC(O)c2ccccc21,DB00321,DrugBank Augmented
DB00559,Bosentan,DBMET01237,Bosentan metabolite Ro 64-1056,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,CC(C)(CO)c1ccc(S(=O)(=O)Nc2nc(-c3ncccn3)nc(OCCO)c2Oc2ccccc2O)cc1,DB00559,DrugBank Augmented
DB00559,Bosentan,DBMET01237,Bosentan metabolite Ro 64-1056,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,CC(C)(CO)c1ccc(S(=O)(=O)Nc2nc(-c3ncccn3)nc(OCCO)c2Oc2ccccc2O)cc1,DB00559,DrugBank Augmented
DB00564,Carbamazepine,DBMET01101,"2,3-Dihydroxycarbamazepine",NC(=O)N1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C=Cc2cc(O)c(O)cc21,DB00564,DrugBank Augmented
DB00580,Valdecoxib,DBMET01342,Valdecoxib metabolite M5,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,O=S(=O)(NO)c1ccc(-c2c(-c3ccccc3)noc2CO)cc1,DB00580,DrugBank Augmented
DB00580,Valdecoxib,DBMET01342,Valdecoxib metabolite M5,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,O=S(=O)(NO)c1ccc(-c2c(-c3ccccc3)noc2CO)cc1,DB00580,DrugBank Augmented
DB00580,Valdecoxib,DBMET01347,Valdecoxib metabolite M3,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,NS(=O)(=O)c1ccc(-c2c(-c3cccc(O)c3)noc2CO)cc1,DB00580,DrugBank Augmented
DB00580,Valdecoxib,DBMET01347,Valdecoxib metabolite M3,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,NS(=O)(=O)c1ccc(-c2c(-c3cccc(O)c3)noc2CO)cc1,DB00580,DrugBank Augmented
DB00608,Chloroquine,DBMET03063,N-bidesethylchloroquine,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,CC(CCCN)Nc1ccnc2cc(Cl)ccc12,DB00608,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02830,5-alpha androstanedione,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00571,5-alpha-Dihydrotestosterone glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00574,5a-Dihydrotestosterone sulfate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02832,5-alpha androstanediol,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02834,"5alpha-androstane-3beta,17beta-diol",CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02831,5-alpha androsterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00558,Dihydrotestosterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02831,5-alpha androsterone,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2=O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00571,5-alpha-Dihydrotestosterone glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00574,5a-Dihydrotestosterone sulfate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02832,5-alpha androstanediol,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02834,"5alpha-androstane-3beta,17beta-diol",CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02862,"17α,20ξ,21-trihydroxy-5ξ-pregn-1-en-3,11-dione(M-XVIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02852,"6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-X)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02854,"6β,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-VIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02857,"6β,11β,17α,20α,21-pentahydroxypregnan-1,4-diene-3-one (M-IX)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB00661,Verapamil,DBMET01234,Verapamil metabolite D-620,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,DB00661,DrugBank Augmented
DB00661,Verapamil,DBMET01234,Verapamil metabolite D-620,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,DB00661,DrugBank Augmented
DB00661,Verapamil,DBMET01234,Verapamil metabolite D-620,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,DB00661,DrugBank Augmented
DB00674,Galantamine,DBMET03141,O-desmethyl-galantamine glucuronide,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(OC4C(O)C(O)C(O)C(O)C4C(=O)O)ccc(c23)C1,DB00674,DrugBank Augmented
DB00674,Galantamine,DBMET03142,Sulfate conjugate of O-desmethyl-galantamine,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(OS(=O)(=O)O)ccc(c23)C1,DB00674,DrugBank Augmented
DB00675,Tamoxifen,DBMET01044,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET01044,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET00737,4-hydroxytamoxifen sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCN(C)C)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02702,Tamoxifen Glucuronides,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02714,"N,N-didesmethyltamoxifen",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(OCCN)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00682,Warfarin,DBMET02563,(E)-dehydrowarfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,CC(=O)C=C(c1ccccc1)c1c(O)c2ccccc2oc1=O,DB00682,DrugBank Augmented
DB00682,Warfarin,DBMET02564,(Z)-dehydrowarfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,CC(=O)C=C(c1ccccc1)c1c(O)c2ccccc2oc1=O,DB00682,DrugBank Augmented
DB00682,Warfarin,DBMET02563,(E)-dehydrowarfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,CC(=O)C=C(c1ccccc1)c1c(O)c2ccccc2oc1=O,DB00682,DrugBank Augmented
DB00682,Warfarin,DBMET02564,(Z)-dehydrowarfarin,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,CC(=O)C=C(c1ccccc1)c1c(O)c2ccccc2oc1=O,DB00682,DrugBank Augmented
DB00683,Midazolam,DBMET03615,"1,4-dihydroxymidazolam",Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,OCc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2O,DB00683,DrugBank Augmented
DB00683,Midazolam,DBMET03615,"1,4-dihydroxymidazolam",Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,OCc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2O,DB00683,DrugBank Augmented
DB00694,Daunorubicin,DBMET03406,,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)O)CC3,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03406,Deoxydaunorubicinol aglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)O)CC3,DB00694,DrugBank Augmented
DB00717,Norethisterone,DBMET02892,"3α,5α-tetrahydronorethisterone",C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,C#CC1(O)CCC2C3CCC4CC(O)CCC4C3CCC21C,DB00717,DrugBank Augmented
DB00717,Norethisterone,DBMET02893,"3β,5α-tetrahydronorethisterone",C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,C#CC1(O)CCC2C3CCC4CC(O)CCC4C3CCC21C,DB00717,DrugBank Augmented
DB00717,Norethisterone,DBMET02895,"3α,5β-tetrahydronorethisterone",C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,C#CC1(O)CCC2C3CCC4CC(O)CCC4C3CCC21C,DB00717,DrugBank Augmented
DB00717,Norethisterone,DBMET02896,"3β,5β-tetrahydronorethisterone",C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C,C#CC1(O)CCC2C3CCC4CC(O)CCC4C3CCC21C,DB00717,DrugBank Augmented
DB00731,Nateglinide,DBMET01322,Nateglinide metabolite M11/M12,CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,CC(O)(CO)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,DB00731,DrugBank Augmented
DB00731,Nateglinide,DBMET01322,Nateglinide metabolite M11/M12,CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,CC(O)(CO)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,DB00731,DrugBank Augmented
DB00731,Nateglinide,DBMET01322,Nateglinide metabolite M11/M12,CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,CC(O)(CO)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1,DB00731,DrugBank Augmented
DB00755,Tretinoin,DBMET00455,4-Oxoretinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00776,Oxcarbazepine,DBMET02803,"trans-10,11-dihydro-10,11-dihydroxycarbamazepine",NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,DB00776,DrugBank Augmented
DB00776,Oxcarbazepine,DBMET02804,"cis-10,11-dihydro-10,11-dihydroxycarbamazepine",NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,DB00776,DrugBank Augmented
DB00776,Oxcarbazepine,DBMET02803,"trans-10,11-dihydro-10,11-dihydroxycarbamazepine",NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,DB00776,DrugBank Augmented
DB00776,Oxcarbazepine,DBMET02804,"cis-10,11-dihydro-10,11-dihydroxycarbamazepine",NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2C(O)C(O)c2ccccc21,DB00776,DrugBank Augmented
DB00776,Oxcarbazepine,DBMET02805,(R)-MHD glucuronide metabolite,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2CC(OC2OC(C(=O)O)C(O)C(O)C2O)c2ccccc21,DB00776,DrugBank Augmented
DB00776,Oxcarbazepine,DBMET02806,(S)-MHD glucuronide metabolite,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,NC(=O)N1c2ccccc2CC(OC2OC(C(=O)O)C(O)C(O)C2O)c2ccccc21,DB00776,DrugBank Augmented
DB13952,Estradiol acetate,DBMET01658,4-Hydroxyestradiol,CC(=O)Oc1ccc2c(c1)CCC1C2CCC2(C)C(O)CCC12,CC12CCC3c4ccc(O)c(O)c4CCC3C1CCC2O,DB13952,DrugBank Augmented
DB00818,Propofol,DBMET01311,1-Quinol glucuronide,CC(C)c1cccc(C(C)C)c1O,CC(C)c1cc(O)cc(C(C)C)c1OC1OC(C(=O)O)C(O)C(O)C1O,DB00818,DrugBank Augmented
DB00818,Propofol,DBMET01311,1-Quinol glucuronide,CC(C)c1cccc(C(C)C)c1O,CC(C)c1cc(O)cc(C(C)C)c1OC1OC(C(=O)O)C(O)C(O)C1O,DB00818,DrugBank Augmented
DB00818,Propofol,DBMET01312,4-Quinol sulfate,CC(C)c1cccc(C(C)C)c1O,CC(C)c1cc(OS(=O)(=O)O)cc(C(C)C)c1O,DB00818,DrugBank Augmented
DB00853,Temozolomide,DBMET03268,5-aminoimidazole-4-carboxamide (AIC),Cn1nnc2c(C(N)=O)ncn2c1=O,Cn1nnc2c(C(N)=O)ncn2c1=O,DB00853,DrugBank Augmented
DB00853,Temozolomide,DBMET03269,Methyl diazonium,Cn1nnc2c(C(N)=O)ncn2c1=O,Cn1nnc2c(C(N)=O)ncn2c1=O,DB00853,DrugBank Augmented
DB00857,Terbinafine,DBMET01179,N-Desmethylhydroxyterbinafine,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C#CC=CCNCc1cccc2ccccc12)CO,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01179,N-Desmethylhydroxyterbinafine,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C#CC=CCNCc1cccc2ccccc12)CO,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01180,1-Naphthoic acid,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,O=C(O)c1cccc2ccccc12,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01181,1-Naphthalenemethanol,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,OCc1cccc2ccccc12,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01205,N-Desmethylterbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C)C#CC=CCNCc1cc(O)c(O)c2ccccc12,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01206,N-Desmethylterbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C)C#CC=CCNCc1cccc2c(O)c(O)ccc12,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01205,N-Desmethylterbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C)C#CC=CCNCc1cc(O)c(O)c2ccccc12,DB00857,DrugBank Augmented
DB00857,Terbinafine,DBMET01206,N-Desmethylterbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,CC(C)(C)C#CC=CCNCc1cccc2c(O)c(O)ccc12,DB00857,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02852,"6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-X)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02854,"6β,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-VIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02857,"6β,11β,17α,20α,21-pentahydroxypregnan-1,4-diene-3-one (M-IX)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02862,"17α,20ξ,21-trihydroxy-5ξ-pregn-1-en-3,11-dione(M-XVIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB00921,Buprenorphine,DBMET01295,Hydroxynorbuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(O)c5c4C3(CCN1CC1CC1)C2O5,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(O)c5c4C3(CCN1)C2O5,DB00921,DrugBank Augmented
DB00921,Buprenorphine,DBMET01295,Hydroxynorbuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(O)c5c4C3(CCN1CC1CC1)C2O5,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(O)c5c4C3(CCN1)C2O5,DB00921,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02685,6-α-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02684,6-β-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02724,6-β-hydromorphol glucuronide conjugate 1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02725,6-β-hydromorphol glucuronide conjugate 2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02726,6-α-hydromorphol glucuronide conjugate 1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02727,6-α-hydromorphol glucuronide conjugate 2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02726,6-α-hydromorphol glucuronide conjugate 1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02727,6-α-hydromorphol glucuronide conjugate 2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02724,6-β-hydromorphol glucuronide conjugate 1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(OC6OC(C(=O)O)C(O)C(O)C6O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02725,6-β-hydromorphol glucuronide conjugate 2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)CCC3C1C5,DB15465,DrugBank Augmented
DB00959,Methylprednisolone,DBMET02925,Methylprednisolone M10 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1(O)CC2C(C(O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented
DB00959,Methylprednisolone,DBMET02924,Methylprednisolone M9 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1(O)CC2C(C(O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented
DB00959,Methylprednisolone,DBMET02927,Methylprednisolone M5 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1=CC2C(C(O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented
DB00959,Methylprednisolone,DBMET02928,Methylprednisolone M6 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1=CC2C(C(O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented
DB00959,Methylprednisolone,DBMET02933,Methylprednisolone M11 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1CC2C(C(=O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented
DB00959,Methylprednisolone,DBMET02934,Methylprednisolone M12 Metabolite,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,CC1CC2C(C(=O)CC3(C)C2CCC3(O)C(O)CO)C2(C)C=CC(=O)C=C12,DB00959,DrugBank Augmented
DB00968,Methyldopa,DBMET03314,Alpha-methylnorepinephrine,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,CC(N)C(O)c1ccc(O)c(O)c1,DB00968,DrugBank Augmented
DB00755,Tretinoin,DBMET02549,4-hydroxy-all-trans-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00755,Tretinoin,DBMET02552,4-oxo-13-cis-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET01200,"N,N-Didesmethyldiphenhydramine",Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,NCCOC(c1ccccc1)c1ccccc1,DB00985,DrugBank Augmented
DB00997,Doxorubicin,DBMET00847,Doxorubicinol deoxaglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB00997,Doxorubicin,DBMET00847,Doxorubicinol deoxaglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB01015,Sulfamethoxazole,DBMET01048,N4-Acetyl-5-OH-sulfamethoxazole,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(CO)on2)cc1,DB01015,DrugBank Augmented
DB01015,Sulfamethoxazole,DBMET01048,N4-Acetyl-5-OH-sulfamethoxazole,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(CO)on2)cc1,DB01015,DrugBank Augmented
DB01029,Irbesartan,DBMET01055,Irbesartan derivative M1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB01029,Irbesartan,DBMET01055,Irbesartan derivative M1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB01029,Irbesartan,DBMET01055,Irbesartan derivative M1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB01033,Mercaptopurine,DBMET01158,Methyl-thioinosine 5'-monophospate,S=c1nc[nH]c2nc[nH]c12,CSc1ncnc2c1ncn2C1OC(COP(=O)(O)O)C(O)C1O,DB01033,DrugBank Augmented
DB00352,Tioguanine,DBMET01153,Methyl-thioguanosine monophosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,CSC1N=C(N)Nc2c1ncn2C1OC(COP(=O)(O)O)C(O)C1O,DB00352,DrugBank Augmented
DB00352,Tioguanine,DBMET01154,Thioguanosine diphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3OC(COP(=O)(O)OP(=O)(O)O)C(O)C3O)c2[nH]1,DB00352,DrugBank Augmented
DB01036,Tolterodine,DBMET01256,N-Dealkylated 5-hydroxymethyl tolterodine,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,CC(C)NCCC(c1ccccc1)c1cc(CO)ccc1O,DB01036,DrugBank Augmented
DB01036,Tolterodine,DBMET01256,N-Dealkylated 5-hydroxymethyl tolterodine,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,CC(C)NCCC(c1ccccc1)c1cc(CO)ccc1O,DB01036,DrugBank Augmented
DB01041,Thalidomide,DBMET01120,2-(o-carboxybenzamido)glutaramic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(=O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01117,2-phthalimidoglutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01117,2-phthalimidoglutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(C(=O)O)N1C(=O)c2ccccc2C1=O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01120,2-(o-carboxybenzamido)glutaramic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(=O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET03444,"cis,trans-5,5’-dihydroxythalidomide",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C1NC(=O)C(N2C(=O)c3ccc(O)cc3C2=O)CC1O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET03444,"cis,trans-5,5’-dihydroxythalidomide",O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C1NC(=O)C(N2C(=O)c3ccc(O)cc3C2=O)CC1O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01065,Melatonin,DBMET00762,6-Hydroxymelatonin glucuronide,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,COc1cc2c(CCNC(C)=O)c[nH]c2cc1OC1OC(C(=O)O)C(O)C(O)C1O,DB01065,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET01200,"N,N-Didesmethyldiphenhydramine",Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,NCCOC(c1ccccc1)c1ccccc1,DB00985,DrugBank Augmented
DB01086,Benzocaine,DBMET03290,4-Acetaminobenzoic acid,CCOC(=O)c1ccc(N)cc1,CC(=O)Nc1ccc(C(=O)O)cc1,DB01086,DrugBank Augmented
DB00322,Floxuridine,DBMET03581,dihydrofluorouracil (DHFU),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=C1NCC(F)C(=O)N1,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03586,5-fluorouridine monophosphate (5-FUMP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB01132,Pioglitazone,DBMET01303,Pioglitazone metabolite M-XI,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,CC(O)c1ccc(C(O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1,DB01132,DrugBank Augmented
DB01132,Pioglitazone,DBMET01303,Pioglitazone metabolite M-XI,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,CC(O)c1ccc(C(O)COc2ccc(CC3SC(=O)NC3=O)cc2)nc1,DB01132,DrugBank Augmented
DB01142,Doxepin,DBMET00881,Hydroxydoxepin glucuronide,CN(C)CCC=C1c2ccccc2COc2ccccc21,CN(C)CCC=C1c2ccccc2COc2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc21,DB01142,DrugBank Augmented
DB01142,Doxepin,DBMET00872,Hydroxydesmethyl doxepin,CN(C)CCC=C1c2ccccc2COc2ccccc21,CNCCC=C1c2ccccc2COc2ccc(O)cc21,DB01142,DrugBank Augmented
DB01142,Doxepin,DBMET00874,(E)-2-hydroxy-N-desmethyldoxepin,CN(C)CCC=C1c2ccccc2COc2ccccc21,CNCCC=C1c2ccccc2COc2ccc(O)cc21,DB01142,DrugBank Augmented
DB01151,Desipramine,DBMET00679,2-hydroxy-desipramine glucuronide,CNCCCN1c2ccccc2CCc2ccccc21,CNCCCN1c2ccccc2CCc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc21,DB01151,DrugBank Augmented
DB01156,Bupropion,DBMET03485,"S,R-erythro-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03486,"S,R-erythrohydrobupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03477,"S,S-threo-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03480,"R,S-erythro-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03474,"R,R-threo-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03480,"R,S-erythro-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03487,S-4'-hydroxybupropion glucuronide,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(=O)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03488,R-4'-hydroxybupropion glucuronide,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(=O)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03490,R-4'-hydroxybupropion sulfate,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(=O)c1ccc(OS(=O)(=O)O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03489,S-4'-hydroxybupropion sulfate,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(=O)c1ccc(OS(=O)(=O)O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03469,"S,S-Hydroxybupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC1NC(C)(C)COC1(O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03471,"R,R-Hydroxybupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC1NC(C)(C)COC1(O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03474,"R,R-threo-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03475,"R,R-threohydrobupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03477,"S,S-threo-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03480,"R,S-erythro-4'-hydroxy-hydrobupropion",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(O)c1ccc(O)c(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03481,"R,S-erythrohydrobupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC(NC(C)(C)C)C(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01175,Escitalopram,DBMET03673,Escitalopram propionaldehyde,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC=O)c1ccc(F)cc1,DB01175,DrugBank Augmented
DB01175,Escitalopram,DBMET02783,Escitalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB01175,DrugBank Augmented
DB01175,Escitalopram,DBMET02782,S-didesmethylcitalopram,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCCN)c1ccc(F)cc1,DB01175,DrugBank Augmented
DB01175,Escitalopram,DBMET02783,Escitalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB01175,DrugBank Augmented
DB01175,Escitalopram,DBMET02783,Escitalopram propionic acid,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC(=O)O)c1ccc(F)cc1,DB01175,DrugBank Augmented
DB01221,Ketamine,DBMET01308,4-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CC(O)CCC1=O,DB01221,DrugBank Augmented
DB01221,Ketamine,DBMET01309,5-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CCC(O)CC1=O,DB01221,DrugBank Augmented
DB01221,Ketamine,DBMET01310,6-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CCCC(O)C1=O,DB01221,DrugBank Augmented
DB01221,Ketamine,DBMET01310,6-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CCCC(O)C1=O,DB01221,DrugBank Augmented
DB01221,Ketamine,DBMET01309,5-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CCC(O)CC1=O,DB01221,DrugBank Augmented
DB01221,Ketamine,DBMET01308,4-Hydroxynorketamine,CNC1(c2ccccc2Cl)CCCCC1=O,NC1(c2ccccc2Cl)CC(O)CCC1=O,DB01221,DrugBank Augmented
DB01242,Clomipramine,DBMET00835,didesmethylclomipramine,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,NCCCN1c2ccccc2CCc2ccc(Cl)cc21,DB01242,DrugBank Augmented
DB01255,Lisdexamfetamine,DBMET03722,4-Hydroxy-norephedrine,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,CC(N)C(O)c1ccc(O)cc1,DB01255,DrugBank Augmented
DB01275,Hydralazine,DBMET02815,Phthalazinone,NNc1nncc2ccccc12,O=c1[nH]ncc2ccccc12,DB01275,DrugBank Augmented
DB01275,Hydralazine,DBMET02815,Phthalazinone,NNc1nncc2ccccc12,O=c1[nH]ncc2ccccc12,DB01275,DrugBank Augmented
DB01280,Nelarabine,DB02377,Guanine,COc1nc(N)nc2c1ncn2C1OC(CO)C(O)C1O,Nc1nc(=O)c2[nH]cnc2[nH]1,DB01280,DrugBank Augmented
DB01280,Nelarabine,DB02377,Guanine,COc1nc(N)nc2c1ncn2C1OC(CO)C(O)C1O,Nc1nc(=O)c2[nH]cnc2[nH]1,DB01280,DrugBank Augmented
DB01283,Lumiracoxib,DBMET01284,Lumiracoxib metabolite M9,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(CO)ccc1Nc1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented
DB01283,Lumiracoxib,DBMET01284,Lumiracoxib metabolite M9,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(CO)ccc1Nc1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00593,3-alpha-Androstanediol glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01452,Diamorphine,DBMET00313,morphine,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,DB01452,DrugBank Augmented
DB01628,Etoricoxib,DBMET01273,6-Hydroxymethyletoricoxib glucuronide,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,CS(=O)(=O)c1ccc(-c2cc(Cl)cnc2-c2ccc(COC3OC(C(=O)O)C(O)C(O)C3O)nc2)cc1,DB01628,DrugBank Augmented
DB06419,Cethromycin,DBMET03137,10-hydroxy-N-desmethyl cethromycin,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OCC=Cc2cnc3ccccc3c2)CC(C)C(=O)C(C)C2NC(=O)OC12C,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC(NC)C2O)C(C)(OCC=Cc2cnc3ccccc3c2)CC(C)C(=O)C(CO)C2NC(=O)OC12C,DB06419,DrugBank Augmented
DB06419,Cethromycin,DBMET03137,10-hydroxy-N-desmethyl cethromycin,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OCC=Cc2cnc3ccccc3c2)CC(C)C(=O)C(C)C2NC(=O)OC12C,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC(NC)C2O)C(C)(OCC=Cc2cnc3ccccc3c2)CC(C)C(=O)C(CO)C2NC(=O)OC12C,DB06419,DrugBank Augmented
DB06695,Dabigatran etexilate,DB14726,Dabigatran,CCCCCCOC(=O)N=C(N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB06695,DrugBank Augmented
DB06695,Dabigatran etexilate,DB14726,Dabigatran,CCCCCCOC(=O)N=C(N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB06695,DrugBank Augmented
DB14726,Dabigatran,DBMET03382,Dabigatran M369,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented
DB14726,Dabigatran,DBMET03382,Dabigatran M369,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented
DB00285,Venlafaxine,DBMET00958,"N,O-didesmethylvenlafaxine glucuronide",COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CNCC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,DB00285,DrugBank Augmented
DB06751,Drotaverine,DBMET03304,4'-desethyl-drotaveraldine,CCOc1ccc(C=C2NCCc3cc(OCC)c(OCC)cc32)cc1OCC,CCOc1cc2c(cc1O)CCNC2C(=O)c1ccc(OCC)c(OCC)c1,DB06751,DrugBank Augmented
DB06751,Drotaverine,DBMET03304,4'-desethyl-drotaveraldine,CCOc1ccc(C=C2NCCc3cc(OCC)c(OCC)cc32)cc1OCC,CCOc1cc2c(cc1O)CCNC2C(=O)c1ccc(OCC)c(OCC)c1,DB06751,DrugBank Augmented
DB07565,Chloramphenicol succinate,DBMET03162,Chloramphenicol Oxamic Acid,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(O)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented
DB07565,Chloramphenicol succinate,DBMET03163,Chloramphenicol Oxamyl Ethanolamine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(NCO)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented
DB07565,Chloramphenicol succinate,DBMET03164,Chloramphenicol Oxamyl Glycine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(O)CNC(=O)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented
DB07565,Chloramphenicol succinate,DBMET03163,Chloramphenicol Oxamyl Ethanolamine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(NCO)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented
DB07565,Chloramphenicol succinate,DBMET03164,Chloramphenicol Oxamyl Glycine,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)c1ccc([N+](=O)[O-])cc1,O=C(O)CNC(=O)C(=O)NC(CO)C(O)c1ccc([N+](=O)[O-])cc1,DB07565,DrugBank Augmented
DB08882,Linagliptin,DBMET02384,Linagliptin M531(1),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC(=O)NC1CCCN(c2nc3c(c(=O)n(Cc4nc(C)c5ccccc5n4)c(=O)n3C)n2CC#CCO)C1,DB08882,DrugBank Augmented
DB08882,Linagliptin,DBMET02384,Linagliptin M531(1),CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CC(=O)NC1CCCN(c2nc3c(c(=O)n(Cc4nc(C)c5ccccc5n4)c(=O)n3C)n2CC#CCO)C1,DB08882,DrugBank Augmented
DB08893,Mirabegron,DBMET03333,Mirabegron M5 metabolite,Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1,Nc1ccc(CCNCC(O)c2ccccc2)cc1,DB08893,DrugBank Augmented
DB08893,Mirabegron,DBMET03334,Mirabegron M17 metabolite,Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1,Nc1ccc(CCNCC(O)c2ccccc2)cc1,DB08893,DrugBank Augmented
DB08921,(4R)-limonene,DBMET01191,Uroterpenol-O-glucuronide,C=C(C)C1CC=C(C)CC1,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,DB08921,DrugBank Augmented
DB08921,(4R)-limonene,DBMET01191,Uroterpenol-O-glucuronide,C=C(C)C1CC=C(C)CC1,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,DB08921,DrugBank Augmented
DB09039,Eliglustat,DBMET03454,Genz-682042,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented
DB09042,Tedizolid phosphate,DBMET03124,Desmethyl tedizolid sulphate,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,O=C1OC(C=S(=O)(O)O)CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,DB09042,DrugBank Augmented
DB09042,Tedizolid phosphate,DBMET03124,Desmethyl tedizolid sulphate,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,O=C1OC(C=S(=O)(O)O)CN1c1ccc(-c2ccc(-c3nn[nH]n3)nc2)c(F)c1,DB09042,DrugBank Augmented
DB09042,Tedizolid phosphate,DBMET03127,Ring-opened tedizolid metabolite,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,Cn1nnc(-c2ccc(-c3ccc(NCC(=O)O)cc3F)cn2)n1,DB09042,DrugBank Augmented
DB09053,Ibrutinib,DBMET02024,M17,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,C=CC(=O)NCC(CCCO)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,DB09053,DrugBank Augmented
DB09053,Ibrutinib,DBMET02024,M17,C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,C=CC(=O)NCC(CCCO)n1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,DB09053,DrugBank Augmented
DB09072,Sodium oxybate,DBMET01477,Succinic Acid,O=C(O)CCCO,O=C(O)CCC(=O)O,DB09072,DrugBank Augmented
DB09072,Sodium oxybate,DBMET01477,Succinic Acid,O=C(O)CCCO,O=C(O)CCC(=O)O,DB09072,DrugBank Augmented
DB09194,Etoperidone,DBMET02176,Etoperidone M8,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCCN2CCN(c3ccc(O)c(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented
DB09194,Etoperidone,DBMET02177,Etoperidone M9,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCC[N+]2([O-])CC[N+]([O-])(c3cccc(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented
DB09194,Etoperidone,DBMET02178,Etoperidone M15,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCC(=O)O)c1=O,DB09194,DrugBank Augmented
DB09194,Etoperidone,DBMET02177,Etoperidone M9,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCC[N+]2([O-])CC[N+]([O-])(c3cccc(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented
DB09194,Etoperidone,DBMET02176,Etoperidone M8,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCCN2CCN(c3ccc(O)c(Cl)c3)CC2)c1=O,DB09194,DrugBank Augmented
DB09194,Etoperidone,DBMET02183,Etoperidone M14,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC,CCn1c(C(C)O)nn(CCC(=O)O)c1=O,DB09194,DrugBank Augmented
DB09229,Aranidipine,DBMET01951,Aranidipine M-4,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)O)c1-c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented
DB09229,Aranidipine,DBMET01951,Aranidipine M-4,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)O)c1-c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented
DB00300,Tenofovir disoproxil,DBMET01177,Tenofovir Diphosphate,CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C,CC(Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,DB00300,DrugBank Augmented
DB00322,Floxuridine,DBMET02004,5-FUH2,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=C1NCC(F)C(=O)N1,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET01999,5-fluorodeoxyuridine-monophosphate,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET02000,5-fluorouridine-triphosphate,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB01452,Diamorphine,DBMET00313,morphine,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,DB01452,DrugBank Augmented
DB11251,,DBMET02035,13'-carboxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11677,Triheptanoin,DBMET03176,Propionyl Coenzyme A,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,CCC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1OP(=O)(O)O,DB11677,DrugBank Augmented
DB11682,Daprodustat,DBMET03603,Daprodustat M13 metabolite,O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,O=C(O)CNC(=O)C1C(=O)N(C2CCC(O)C(O)C2)C(=O)N(C2CCC(O)CC2)C1O,DB11682,DrugBank Augmented
DB11689,Selumetinib,DBMET03101,"M12 (Primary amide, N-demethylated selumetinib metabolite)",Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,NC(=O)c1cc2[nH]cnc2c(F)c1Nc1ccc(Br)cc1Cl,DB11689,DrugBank Augmented
DB11689,Selumetinib,DBMET03101,"M12 (Primary amide, N-demethylated selumetinib metabolite)",Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,NC(=O)c1cc2[nH]cnc2c(F)c1Nc1ccc(Br)cc1Cl,DB11689,DrugBank Augmented
DB11763,Momelotinib,DBMET03712,Momelotinib M8 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,NC(=O)CNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented
DB11763,Momelotinib,DBMET03711,Momelotinib M14 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,O=C(O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented
DB11763,Momelotinib,DBMET03712,Momelotinib M8 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,NC(=O)CNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented
DB12016,Ponesimod,DBMET03310,Ponesimod M48 Metabolite,CCCN=C1SC(=Cc2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,CCCN=C1SC(=Cc2ccc(O)c(Cl)c2)C(O)N1c1ccccc1C,DB12016,DrugBank Augmented
DB12016,Ponesimod,DBMET03309,Ponesimod M32 Metabolite,CCCN=C1SC(=Cc2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,CCCN=C1SC(=Cc2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C,DB12016,DrugBank Augmented
DB12016,Ponesimod,DBMET03310,Ponesimod M48 Metabolite,CCCN=C1SC(=Cc2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,CCCN=C1SC(=Cc2ccc(O)c(Cl)c2)C(O)N1c1ccccc1C,DB12016,DrugBank Augmented
DB12016,Ponesimod,DBMET03310,Ponesimod M48 Metabolite,CCCN=C1SC(=Cc2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,CCCN=C1SC(=Cc2ccc(O)c(Cl)c2)C(O)N1c1ccccc1C,DB12016,DrugBank Augmented
DB12184,Gepirone,DBMET03724,"3',5-di-OH-gepirone",CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,CC1(C)CC(=O)N(CCCCN2CCN(c3ncc(O)cn3)CC2)C(=O)C1O,DB12184,DrugBank Augmented
DB12184,Gepirone,DBMET03724,"3',5-di-OH-gepirone",CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,CC1(C)CC(=O)N(CCCCN2CCN(c3ncc(O)cn3)CC2)C(=O)C1O,DB12184,DrugBank Augmented
DB12184,Gepirone,DBMET03726,5-OH 1-PP,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,Oc1cnc(N2CCNCC2)nc1,DB12184,DrugBank Augmented
DB12184,Gepirone,DBMET03726,5-OH 1-PP,CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,Oc1cnc(N2CCNCC2)nc1,DB12184,DrugBank Augmented
DB13783,Acemetacin,DBMET02187,O-desmethyl-des-4-chlorobenzoyl glucuronide,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,COc1ccc2c(c1)c(CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)c(C)n2C(=O)c1ccc(Cl)cc1,DB13783,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00593,3-alpha-Androstanediol glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET00593,3-alpha-Androstanediol glucuronide,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02381,3-alpha-androstanediol,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB01420,Testosterone propionate,DBMET02382,3-beta-androstenediol,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,DB01420,DrugBank Augmented
DB11251,,DBMET02035,13'-carboxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02035,13'-carboxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02035,13'-carboxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB00300,Tenofovir disoproxil,DBMET01177,Tenofovir Diphosphate,CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C,CC(Cn1cnc2c(N)ncnc21)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,DB00300,DrugBank Augmented
DB14512,Mometasone furoate,DBMET02369,"21-beta-chloro-21-alpha-hydroxy-16-alpha-methyl-9-beta,11-beta-oxidopregna-1,4,17,20-tetraen-3-one 21-(2-furoate",CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,CC1CC2C3CCC4=CC(=O)C=CC4(C)C34OC4CC2(C)C1=C=C(Cl)OC(=O)c1ccco1,DB14512,DrugBank Augmented
DB14512,Mometasone furoate,DBMET02369,"21-beta-chloro-21-alpha-hydroxy-16-alpha-methyl-9-beta,11-beta-oxidopregna-1,4,17,20-tetraen-3-one 21-(2-furoate",CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,CC1CC2C3CCC4=CC(=O)C=CC4(C)C34OC4CC2(C)C1=C=C(Cl)OC(=O)c1ccco1,DB14512,DrugBank Augmented
DB14761,Remdesivir,DBMET03036,Remdesivir Nucleoside Monophosphate,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(COP(=O)(O)O)C(O)C1O,DB14761,DrugBank Augmented
DB14761,Remdesivir,DBMET03036,Remdesivir Nucleoside Monophosphate,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(COP(=O)(O)O)C(O)C1O,DB14761,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02685,6-α-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15465,Benzhydrocodone,DBMET02684,6-β-hydromorphol,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,CN1CCC23c4c5ccc(O)c4OC2C(O)CCC3C1C5,DB15465,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02852,"6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-X)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02854,"6β,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one (M-VIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02857,"6β,11β,17α,20α,21-pentahydroxypregnan-1,4-diene-3-one (M-IX)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02862,"17α,20ξ,21-trihydroxy-5ξ-pregn-1-en-3,11-dione(M-XVIII)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB16217,Leniolisib,DBMET03656,Leniolisib M48 metabolite,CCC(=O)N1CCC(Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,Nc1ncnc2c1CN(c1cnc(O)c(C(F)(F)F)c1)CC2,DB16217,DrugBank Augmented
DB16217,Leniolisib,DBMET03656,Leniolisib M48 metabolite,CCC(=O)N1CCC(Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,Nc1ncnc2c1CN(c1cnc(O)c(C(F)(F)F)c1)CC2,DB16217,DrugBank Augmented
DB11635,,DBMET02320,alpha-carboxydimethyldecadienylhydroxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCC(=O)O)O2,DB11635,DrugBank Augmented
DB00193,Tramadol,DBMET00956,"N,N,O-tridesmethyl-tramadol",COc1cccc(C2(O)CCCCC2CN(C)C)c1,NCC1CCCCC1(O)c1cccc(O)c1,DB00193,DrugBank Augmented
DB00193,Tramadol,DBMET00956,"N,N,O-tridesmethyl-tramadol",COc1cccc(C2(O)CCCCC2CN(C)C)c1,NCC1CCCCC1(O)c1cccc(O)c1,DB00193,DrugBank Augmented
DB00215,Citalopram,DBMET03706,Citalopram propionic aldehyde,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC=O)c1ccc(F)cc1,DB00215,DrugBank Augmented
DB00252,Phenytoin,DBMET00989,Phenytoin catechol,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,O=C1NC(=O)C(c2ccccc2)(c2ccc(O)c(O)c2)N1,DB00252,DrugBank Augmented
DB00252,Phenytoin,DBMET00989,Phenytoin catechol,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,O=C1NC(=O)C(c2ccccc2)(c2ccc(O)c(O)c2)N1,DB00252,DrugBank Augmented
DB00281,Lidocaine,DBMET01089,"2,6-Dimethylaniline (2,6-Xylidine)",CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C)c1N,DB00281,DrugBank Augmented
DB00352,Tioguanine,DBMET01155,Thioguanosine triphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C3O)c2[nH]1,DB00352,DrugBank Augmented
DB00352,Tioguanine,DBMET01156,Thiodeoxyguanosine diphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3CC(O)C(COP(=O)(O)OP(=O)(O)O)O3)c2[nH]1,DB00352,DrugBank Augmented
DB00409,Remoxipride,DBMET03196,Remoxipride Metabolite NCM 009,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1(O)CCC(=O)N1,DB00409,DrugBank Augmented
DB00409,Remoxipride,DBMET03196,Remoxipride Metabolite NCM 009,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1(O)CCC(=O)N1,DB00409,DrugBank Augmented
DB00409,Remoxipride,DBMET03196,Remoxipride Metabolite NCM 009,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1ccc(Br)c(OC)c1C(=O)NCC1(O)CCC(=O)N1,DB00409,DrugBank Augmented
DB00421,Spironolactone,DBMET02484,3alpha-hydroxythiomethylspironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,CSC1CC2=CC(O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,DB00421,DrugBank Augmented
DB00421,Spironolactone,DBMET02485,3beta-hydroxythiomethylspironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,CSC1CC2=CC(O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,DB00421,DrugBank Augmented
DB00461,Nabumetone,DBMET02531,reduced O-desmethyl-3-hydroxy-nabumetone,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02531,reduced O-desmethyl-3-hydroxy-nabumetone,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02538,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated),COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02541,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated),COc1ccc2cc(CCC(C)=O)ccc2c1,CC(CCc1ccc2cc(O)ccc2c1)OC1OC(C(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02538,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated),COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02541,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated),COc1ccc2cc(CCC(C)=O)ccc2c1,CC(CCc1ccc2cc(O)ccc2c1)OC1OC(C(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented
DB00476,Duloxetine,DBMET02507,"5-hydroxy, 6-methoxy duloxetine",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(O)c(OC)ccc12)c1cccs1,DB00476,DrugBank Augmented
DB00476,Duloxetine,DBMET02507,"5-hydroxy, 6-methoxy duloxetine",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(O)c(OC)ccc12)c1cccs1,DB00476,DrugBank Augmented
DB00502,Haloperidol,DBMET01212,Haloperidol pyridinium ion derivative,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)c1ccc(F)cc1,DB00502,DrugBank Augmented
DB00531,Cyclophosphamide,DBMET01088,Carboxyphosphamide,O=P1(N(CCCl)CCCl)NCCCO1,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,DB00531,DrugBank Augmented
DB00531,Cyclophosphamide,DBMET01088,Carboxyphosphamide,O=P1(N(CCCl)CCCl)NCCCO1,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,DB00531,DrugBank Augmented
DB00549,Zafirlukast,DBMET01253,Zafirlukast metabolite M3,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1c[nH]c2ccc(NC(C)=O)cc12,DB00549,DrugBank Augmented
DB00564,Carbamazepine,DBMET02601,Carbamazepine-o-quinione,NC(=O)N1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C=Cc2cc(O)c(O)cc21,DB00564,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02855,"6β,11β,17α,20β,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02858,"6β,11β,17α,20α,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XVI)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB00674,Galantamine,DBMET03151,N-desmethyl-epigalantamine,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(O)ccc(c23)C1,DB00674,DrugBank Augmented
DB00674,Galantamine,DBMET03156,O-desmethyl-epigalantamine,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(O)ccc(c23)C1,DB00674,DrugBank Augmented
DB00675,Tamoxifen,DBMET01044,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02702,Tamoxifen Glucuronides,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02700,4-endoxifen Sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET00737,4-hydroxytamoxifen sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCN(C)C)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02702,Tamoxifen Glucuronides,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02700,4-endoxifen Sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET00737,4-hydroxytamoxifen sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCN(C)C)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02719,"Norendoxifen (4-hydroxy-N,N-didesmethyltamoxifen)",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCN)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02719,"Norendoxifen (4-hydroxy-N,N-didesmethyltamoxifen)",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCN)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02702,Tamoxifen Glucuronides,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02700,4-endoxifen Sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00675,Tamoxifen,DBMET02719,"Norendoxifen (4-hydroxy-N,N-didesmethyltamoxifen)",CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCN)cc1)c1ccccc1,DB00675,DrugBank Augmented
DB00694,Daunorubicin,DBMET03406,Deoxydaunorubicinol aglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)O)CC3,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03408,Deoxydaunorubicinol aglycone-13-O-β-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)OOC1OC(C(=O)O)C(O)C(O)C1O)CC3,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03407,Demethyl deoxydaunorubicinol aglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,CC(O)C1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(O)c1C3=O,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03407,Demethyl deoxydaunorubicinol aglycone,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,CC(O)C1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(O)c1C3=O,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03408,Deoxydaunorubicinol aglycone-13-O-β-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)OOC1OC(C(=O)O)C(O)C(O)C1O)CC3,DB00694,DrugBank Augmented
DB00808,Indapamide,DBMET01333,Indapamide metabolite M2,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CC1C(=O)c2cc(O)ccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,DB00808,DrugBank Augmented
DB00808,Indapamide,DBMET01333,Indapamide metabolite M2,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CC1C(=O)c2cc(O)ccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,DB00808,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02855,"6β,11β,17α,20β,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02858,"6β,11β,17α,20α,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XVI)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB00949,Felbamate,DBMET01097,3-Carbamoyl-2-phenylpropionic acid,NC(=O)OCC(COC(N)=O)c1ccccc1,NC(=O)OCC(C(=O)O)c1ccccc1,DB00949,DrugBank Augmented
DB00968,Methyldopa,DBMET03315,Alpha-methylepinephrine,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,CC(N)C(O)c1ccc(O)c(O)c1,DB00968,DrugBank Augmented
DB00755,Tretinoin,DBMET02550,4-oxo-all-trans-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00755,Tretinoin,DBMET02550,4-oxo-all-trans-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET01201,Diphenylmethoxyacetic acid,Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,O=C(O)COC(c1ccccc1)c1ccccc1,DB00985,DrugBank Augmented
DB00997,Doxorubicin,DBMET03628,4-O-demethyl deoxaglycone doxorubicinol,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB00997,Doxorubicin,DBMET03628,4-O-demethyl deoxaglycone doxorubicinol,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB01029,Irbesartan,DBMET01056,Irbesartan derivative M2,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB01029,Irbesartan,DBMET01056,Irbesartan derivative M2,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB01029,Irbesartan,DBMET01056,Irbesartan derivative M2,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB01029,Irbesartan,DBMET01056,Irbesartan derivative M2,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,DB01029,DrugBank Augmented
DB00352,Tioguanine,DBMET01155,Thioguanosine triphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C3O)c2[nH]1,DB00352,DrugBank Augmented
DB00352,Tioguanine,DBMET01156,Thiodeoxyguanosine diphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3CC(O)C(COP(=O)(O)OP(=O)(O)O)O3)c2[nH]1,DB00352,DrugBank Augmented
DB01041,Thalidomide,DB00130,L-Glutamine,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(=O)CCC(N)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB00130,L-Glutamine,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(=O)CCC(N)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01121,2-(o-carboxybenzamido)glutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01121,2-(o-carboxybenzamido)glutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01121,2-(o-carboxybenzamido)glutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01121,2-(o-carboxybenzamido)glutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DBMET01121,2-(o-carboxybenzamido)glutaric acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)CCC(NC(=O)c1ccccc1C(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB00985,Dimenhydrinate,DBMET01201,Diphenylmethoxyacetic acid,Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,O=C(O)COC(c1ccccc1)c1ccccc1,DB00985,DrugBank Augmented
DB00322,Floxuridine,DBMET03582,β-ureidopropionic acid (FUPA),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,NC(=O)NCC(F)C(=O)O,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03585,5-fluorodeoxyuridine monophosphate (5-FdUMP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03589,5-fluorouridine diphosphate (5-FUDP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03586,5-fluorouridine monophosphate (5-FUMP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03589,5-fluorouridine diphosphate (5-FUDP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB01142,Doxepin,DBMET00879,Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1c2ccccc2COc2ccccc21,CN(C)CCC=C1c2ccccc2COc2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)cc21,DB01142,DrugBank Augmented
DB01156,Bupropion,DBMET03482,"S,S-Hydroxybupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC1NC(C)(C)COC1(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01156,Bupropion,DBMET03483,"R,R-Hydroxybupropion glucuronide",CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CC1NC(C)(C)COC1(OC1OC(C(=O)O)C(O)C(O)C1O)c1cccc(Cl)c1,DB01156,DrugBank Augmented
DB01175,Escitalopram,DBMET03673,Escitalopram propionaldehyde,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,N#Cc1ccc2c(c1)COC2(CCC=O)c1ccc(F)cc1,DB01175,DrugBank Augmented
DB01235,Levodopa,DBMET02442,Homovanillic acid,NC(Cc1ccc(O)c(O)c1)C(=O)O,COc1cc(CC(=O)O)ccc1O,DB01235,DrugBank Augmented
DB01235,Levodopa,DBMET02442,Homovanillic acid,NC(Cc1ccc(O)c(O)c1)C(=O)O,COc1cc(CC(=O)O)ccc1O,DB01235,DrugBank Augmented
DB01283,Lumiracoxib,DBMET01285,4'-Hydroxy-5-carboxylumiracoxib (M5),Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(C(=O)O)ccc1Nc1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented
DB01283,Lumiracoxib,DBMET01285,4'-Hydroxy-5-carboxylumiracoxib (M5),Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)Cc1cc(C(=O)O)ccc1Nc1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented
DB14726,Dabigatran,DBMET03383,Dabigatran M325,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1cnc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented
DB14726,Dabigatran,DBMET03383,Dabigatran M325,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,Cn1cnc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,DB14726,DrugBank Augmented
DB09039,Eliglustat,DBMET03451,Genz-399240,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented
DB09039,Eliglustat,DBMET03451,Genz-399240,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented
DB09039,Eliglustat,DBMET03454,Genz-682042,CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,O=C(O)CCCC(=O)NC(CN1CCCC1)C(O)c1ccc2c(c1)OCCO2,DB09039,DrugBank Augmented
DB09229,Aranidipine,DBMET01953,Aranidipine M-5,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],COC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented
DB09229,Aranidipine,DBMET01953,Aranidipine M-5,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-],COC(=O)c1c(C)nc(C)c(C(=O)O)c1-c1ccccc1[N+](=O)[O-],DB09229,DrugBank Augmented
DB00322,Floxuridine,DBMET02005,FUPA,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,NC(=O)NCC(F)C(=O)O,DB00322,DrugBank Augmented
DB11251,,DBMET02036,CDMDHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11637,Delamanid,DBMET01969,"(4R,5S)-DM-6721",CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=O)NC1O,DB11637,DrugBank Augmented
DB11637,Delamanid,DBMET01970,"(4S,5S)-DM-6722",CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=O)NC1O,DB11637,DrugBank Augmented
DB11682,Daprodustat,DBMET03603,Daprodustat M13 metabolite,O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O,O=C(O)CNC(=O)C1C(=O)N(C2CCC(O)C(O)C2)C(=O)N(C2CCC(O)CC2)C1O,DB11682,DrugBank Augmented
DB11763,Momelotinib,DBMET03711,Momelotinib M14 metabolite,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1,O=C(O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4=O)cc3)n2)cc1,DB11763,DrugBank Augmented
DB12016,Ponesimod,DBMET03309,Ponesimod M32 Metabolite,CCCN=C1SC(=Cc2ccc(OCC(O)CO)c(Cl)c2)C(=O)N1c1ccccc1C,CCCN=C1SC(=Cc2ccc(O)c(Cl)c2)C(=O)N1c1ccccc1C,DB12016,DrugBank Augmented
DB11677,Triheptanoin,DBMET03176,Propionyl Coenzyme A,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,CCC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(n2cnc3c(N)ncnc32)C(O)C1OP(=O)(O)O,DB11677,DrugBank Augmented
DB11251,,DBMET02036,CDMDHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02036,CDMDHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02036,CDMDHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB14761,Remdesivir,DB15686,GS-441524,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(CO)C(O)C1O,DB14761,DrugBank Augmented
DB14761,Remdesivir,DBMET03038,Remdesivir Nucleoside Triphosphate,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(COP(=O)(O)O[PH](=O)(=O)O[PH](=O)(=O)O)C(O)C1O,DB14761,DrugBank Augmented
DB14761,Remdesivir,DB15686,GS-441524,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(CO)C(O)C1O,DB14761,DrugBank Augmented
DB14761,Remdesivir,DBMET03038,Remdesivir Nucleoside Triphosphate,CCC(CC)COC(=O)C(C)NP(=O)(OCC1OC(C#N)(c2ccc3c(N)ncnn23)C(O)C1O)Oc1ccccc1,N#CC1(c2ccc3c(N)ncnn23)OC(COP(=O)(O)O[PH](=O)(=O)O[PH](=O)(=O)O)C(O)C1O,DB14761,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02855,"6β,11β,17α,20β,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02858,"6β,11β,17α,20α,21-pentahydroxy-5ξ-pregn-1-en-3-one (M-XVI)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(O)CO,DB15566,DrugBank Augmented
DB11635,,DBMET02321,alpha-carboxydimethyloctenylhydroxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)C(=O)O)O2,DB11635,DrugBank Augmented
DB00252,Phenytoin,DBMET00992,Phenytoin quinone,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,O=C1NC(=O)C(C2=CC(=O)C(=O)C=C2)(c2ccccc2)N1,DB00252,DrugBank Augmented
DB00252,Phenytoin,DBMET00991,Phenytoin methylcatechol,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,O=Cc1cc(C2(c3ccccc3)NC(=O)NC2=O)ccc1O,DB00252,DrugBank Augmented
DB00252,Phenytoin,DBMET00992,Phenytoin quinone,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,O=C1NC(=O)C(C2=CC(=O)C(=O)C=C2)(c2ccccc2)N1,DB00252,DrugBank Augmented
DB00252,Phenytoin,DBMET00991,Phenytoin methylcatechol,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,O=Cc1cc(C2(c3ccccc3)NC(=O)NC2=O)ccc1O,DB00252,DrugBank Augmented
DB00352,Tioguanine,DBMET01157,Thiodeoxyguanosine triphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)c2[nH]1,DB00352,DrugBank Augmented
DB00461,Nabumetone,DBMET02532,reduced O-desmethyl-3-hydroxy-nabumetone glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02532,reduced O-desmethyl-3-hydroxy-nabumetone glucuronide,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(OC3OC(C(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02539,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated) glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02542,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated) glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(CCc1ccc2cc(O)ccc2c1)OC1OC(C(=O)NCC(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02539,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (6-OH conjugated) glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)CCc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02542,4-(6-hydroxy-2-naphthyl)- butan-2-ol glucuronide (2-OH conjugated) glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(CCc1ccc2cc(O)ccc2c1)OC1OC(C(=O)NCC(=O)O)C(O)C(O)C1O,DB00461,DrugBank Augmented
DB00476,Duloxetine,DBMET00750,"5-hydroxy, 6-methoxy duloxetine sulfate",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(OS(=O)(=O)O)c(OC)ccc12)c1ccco1,DB00476,DrugBank Augmented
DB00476,Duloxetine,DBMET02509,"5-hydroxy, 6-methoxy duloxetine glucuronide",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(OC3OC(C(=O)O)C(O)C(O)C3O)c(OC)ccc12)c1cccs1,DB00476,DrugBank Augmented
DB00476,Duloxetine,DBMET00750,"5-hydroxy, 6-methoxy duloxetine sulfate",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(OS(=O)(=O)O)c(OC)ccc12)c1ccco1,DB00476,DrugBank Augmented
DB00476,Duloxetine,DBMET02509,"5-hydroxy, 6-methoxy duloxetine glucuronide",CNCCC(Oc1cccc2ccccc12)c1cccs1,CNCCC(Oc1cccc2c(OC3OC(C(=O)O)C(O)C(O)C3O)c(OC)ccc12)c1cccs1,DB00476,DrugBank Augmented
DB00549,Zafirlukast,DBMET01253,Zafirlukast metabolite M3,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1c[nH]c2ccc(NC(C)=O)cc12,DB00549,DrugBank Augmented
DB00564,Carbamazepine,DBMET02600,Iminoquinone,NC(=O)N1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C=Cc2cc(O)c(O)cc21,DB00564,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB00674,Galantamine,DBMET03157,O-desmethyl-epigalantamine glucuronide,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(OC4C(O)C(O)C(O)C(O)C4C(=O)O)ccc(c23)C1,DB00674,DrugBank Augmented
DB00694,Daunorubicin,DBMET03409,Demethyl deoxydaunorubicinol aglycone-4-O-sulfate,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,CC(O)C1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(OS(O)(O)O)c1C3=O,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03410,Demethyl deoxydaunorubicinol aglycone-4-O-β-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,CC(O)C1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(OOC2OC(C(=O)O)C(O)C(O)C2O)c1C3=O,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03409,Demethyl deoxydaunorubicinol aglycone-4-O-sulfate,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,CC(O)C1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(OS(O)(O)O)c1C3=O,DB00694,DrugBank Augmented
DB00694,Daunorubicin,DBMET03410,Demethyl deoxydaunorubicinol aglycone-4-O-β-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(C)=O)CC3OC1CC(N)C(O)C(C)O1,CC(O)C1(O)CCc2c(O)c3c(c(O)c2C1)C(=O)c1cccc(OOC2OC(C(=O)O)C(O)C(O)C2O)c1C3=O,DB00694,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB00755,Tretinoin,DBMET02552,4-oxo-13-cis-retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,DB00755,DrugBank Augmented
DB00997,Doxorubicin,DBMET03629,Demethyldeoxaglycone doxorubicinol 4-O-sulfate,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(OS(=O)(=O)O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB00997,Doxorubicin,DBMET03630,Demethyldeoxaglycone doxorubicinol 4-O-b-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(OC3OC(C(=O)O)C(O)C(O)C3O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB00997,Doxorubicin,DBMET03629,Demethyldeoxaglycone doxorubicinol 4-O-sulfate,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(OS(=O)(=O)O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB00997,Doxorubicin,DBMET03630,Demethyldeoxaglycone doxorubicinol 4-O-b-glucuronide,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(C(=O)CO)CC3OC1CC(N)C(O)C(C)O1,O=C1c2cccc(OC3OC(C(=O)O)C(O)C(O)C3O)c2C(=O)c2c(O)c3c(c(O)c21)CC(O)(C(O)CO)CC3,DB00997,DrugBank Augmented
DB01033,Mercaptopurine,DBMET01158,Methyl-thioinosine 5'-monophospate,S=c1nc[nH]c2nc[nH]c12,CSc1ncnc2c1ncn2C1OC(COP(=O)(O)O)C(O)C1O,DB01033,DrugBank Augmented
DB00352,Tioguanine,DBMET01157,Thiodeoxyguanosine triphosphate,Nc1nc(=S)c2[nH]cnc2[nH]1,Nc1nc(=S)c2ncn(C3CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)c2[nH]1,DB00352,DrugBank Augmented
DB01041,Thalidomide,DB00142,Glutamic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(CCC(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB00142,Glutamic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(CCC(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB00142,Glutamic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(CCC(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB00142,Glutamic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(CCC(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB00142,Glutamic acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,NC(CCC(=O)O)C(=O)O,DB01041,DrugBank Augmented
DB01041,Thalidomide,DB02746,Phthalic Acid,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,O=C(O)c1ccccc1C(=O)O,DB01041,DrugBank Augmented
DB00322,Floxuridine,DB03904,Urea,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,NC(N)=O,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03583,fluoro-β-alanine (FBAL),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,NCC(F)C(=O)O,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03587,5-fluorodeoxyuridine diphosphate (5-FdUDP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)OP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03590,5-fluorouridine triphosphate (5-FUTP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03587,5-fluorodeoxyuridine diphosphate (5-FdUDP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)OP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03590,5-fluorouridine triphosphate (5-FUTP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB01283,Lumiracoxib,DBMET01287,Lumiracoxib metabolite M8,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)c1ccc2c(c1)CC(=O)N2c1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented
DB01283,Lumiracoxib,DBMET01287,Lumiracoxib metabolite M8,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,O=C(O)c1ccc2c(c1)CC(=O)N2c1c(F)cc(O)cc1Cl,DB01283,DrugBank Augmented
DB00322,Floxuridine,DBMET02006,FBAL,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,NCC(F)C(=O)O,DB00322,DrugBank Augmented
DB00322,Floxuridine,DB03904,Urea,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,NC(N)=O,DB00322,DrugBank Augmented
DB11251,,DBMET02037,CDMOHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11637,Delamanid,DBMET01971,(S)-DM-6717,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=O)NC1=O,DB11637,DrugBank Augmented
DB11637,Delamanid,DBMET01971,(S)-DM-6717,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1,CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)OC(=O)NC1=O,DB11637,DrugBank Augmented
DB11251,,DBMET02038,CDMHHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02037,CDMOHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02037,CDMOHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB15566,Prednisolone acetate,DBMET02856,"6β,11β,17α,21-tetrahydroxy-5ξ-pregn-1-en-3,20-dione (M-XIV)",CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,CC12C=CC(=O)CC1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,DB15566,DrugBank Augmented
DB11635,,DBMET02322,alpha-carboxydimethylhexylhydroxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCC(=O)O)O2,DB11635,DrugBank Augmented
DB00461,Nabumetone,DBMET02533,reduced O-desmethyl-3-hydroxy-nabumetone glucuronide glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00461,Nabumetone,DBMET02533,reduced O-desmethyl-3-hydroxy-nabumetone glucuronide glycine conjugate,COc1ccc2cc(CCC(C)=O)ccc2c1,CC(O)C(O)Cc1ccc2cc(OC3OC(C(=O)NCC(=O)O)C(O)C(O)C3O)ccc2c1,DB00461,DrugBank Augmented
DB00949,Felbamate,DBMET01097,3-Carbamoyl-2-phenylpropionic acid,NC(=O)OCC(COC(N)=O)c1ccccc1,NC(=O)OCC(C(=O)O)c1ccccc1,DB00949,DrugBank Augmented
DB00322,Floxuridine,DBMET03588,5-fluorodeoxyuridine triphosphate (5-FdUTP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03588,5-fluorodeoxyuridine triphosphate (5-FdUTP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03585,5-fluorodeoxyuridine monophosphate (5-FdUMP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03592,5-FUDP-hexose,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OC3C(O)CC(O)C(O)C3CO)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03592,5-FUDP-hexose,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2OC(COP(=O)(O)OP(=O)(O)OC3C(O)CC(O)C(O)C3CO)C(O)C2O)cc1F,DB00322,DrugBank Augmented
DB11251,,DBMET02038,CDMHHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02039,CMBHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02039,CMBHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02038,CDMHHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02039,CMBHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02038,CDMHHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02039,CMBHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)C(=O)O)O2,DB11251,DrugBank Augmented
DB11635,,DBMET02323,alpha-caboxymethylbutylhydroxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)C(=O)O)O2,DB11635,DrugBank Augmented
DB00322,Floxuridine,DBMET03585,,O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB00322,Floxuridine,DBMET03585,5-fluorodeoxyuridine monophosphate (5-FdUMP),O=c1[nH]c(=O)n(C2CC(O)C(CO)O2)cc1F,O=c1[nH]c(=O)n(C2CC(O)C(COP(=O)(O)O)O2)cc1F,DB00322,DrugBank Augmented
DB11251,,DBMET02040,CEHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02040,CEHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02040,CEHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11251,,DBMET02040,CEHC,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCC(=O)O)O2,DB11251,DrugBank Augmented
DB11635,,DBMET02324,alpha-carboxyethylhydroxychromanol,,Cc1c(C)c2c(c(C)c1O)CCC(C)(CCC(=O)O)O2,DB11635,DrugBank Augmented
,tamoxifen,,Endoxifen,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,tamoxifen,MetXBioDB Augmented
,l-trofosfamide,,Dechloroethyl cyclophosphamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=P1(NCCCl)NCCCO1,l-trofosfamide,MetXBioDB Augmented
,l-trofosfamide,,2-chloroacetaldehyde,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=CCCl,l-trofosfamide,MetXBioDB Augmented
,l-trofosfamide,,3-Dechloroethylifosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=P1(NCCCl)NCCCO1,l-trofosfamide,MetXBioDB Augmented
,l-trofosfamide,,chloroacetaldehyde,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=CCCl,l-trofosfamide,MetXBioDB Augmented
,l-trofosfamide,,2-Dechloroethylifosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,NP1(=O)OCCCN1CCCl,l-trofosfamide,MetXBioDB Augmented
,l-trofosfamide,,4-Hydroxyifosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,O=P1(NCCCl)OCCC(O)N1CCCl,l-trofosfamide,MetXBioDB Augmented
,(r)-chloroquine,,"(r)-chloroquine, N-desethyl",CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,CC(CCCN)Nc1ccnc2cc(Cl)ccc12,(r)-chloroquine,MetXBioDB Augmented
,lidocaine,,3-Hydroxymonoethyl glycinexylidide,CCN(CC)CC(=O)Nc1c(C)cccc1C,CCNCC(=O)Nc1c(C)ccc(O)c1C,lidocaine,MetXBioDB Augmented
,phenytoin,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(c2ccccc2)(c2ccccc2)C(O)=N1,OC1=NC(c2ccccc2)(c2ccc(O)c(O)c2)C(O)=N1,phenytoin,MetXBioDB Augmented
,phenytoin,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(c2ccccc2)(c2ccccc2)C(O)=N1,OC1=NC(c2ccccc2)(c2ccc(O)c(O)c2)C(O)=N1,phenytoin,MetXBioDB Augmented
,Verapamil,,D-620,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,Verapamil,MetXBioDB Augmented
,Verapamil,,,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,Verapamil,MetXBioDB Augmented
,clomipramine,,N-Didesmethylclomipramine,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,NCCCN1c2ccccc2CCc2ccc(Cl)cc21,clomipramine,MetXBioDB Augmented
,Encainide,,"N,O-didemethylencainide",COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1,O=C(Nc1ccccc1CCC1CCCCN1)c1ccc(O)cc1,Encainide,MetXBioDB Augmented
,Encainide,,"N,O-didemethylencainide",COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1,O=C(Nc1ccccc1CCC1CCCCN1)c1ccc(O)cc1,Encainide,MetXBioDB Augmented
,irbesartan,,M1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,irbesartan,MetXBioDB Augmented
,lidocaine,,3-Hydroxymonoethyl glycinexylidide,CCN(CC)CC(=O)Nc1c(C)cccc1C,CCNCC(=O)Nc1c(C)ccc(O)c1C,lidocaine,MetXBioDB Augmented
,lidocaine,,Glycinexylidide,CCN(CC)CC(=O)Nc1c(C)cccc1C,Cc1cccc(C)c1NC(=O)CN,lidocaine,MetXBioDB Augmented
,tamoxifen,,N-Desdimethyltamoxifen,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccccc1)c1ccc(OCCN)cc1)c1ccccc1,tamoxifen,MetXBioDB Augmented
,tamoxifen,,Endoxifen,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,tamoxifen,MetXBioDB Augmented
,terbinafine,,1-Nahthalenethanol,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,OCc1cccc2ccccc12,terbinafine,MetXBioDB Augmented
,terbinafine,,1-Naphthoic acid,CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12,O=C(O)c1cccc2ccccc12,terbinafine,MetXBioDB Augmented
,Verapamil,,D-620,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,COc1ccc(C(C#N)(CCCN)C(C)C)cc1OC,Verapamil,MetXBioDB Augmented
,4-VINYLCYCLOHEXENE,,VCH-diepoxide,C=CC1CC=CCC1,C1CC2OC2CC1C1CO1,4-VINYLCYCLOHEXENE,MetXBioDB Augmented
,4-VINYLCYCLOHEXENE,,VCH-diepoxide,C=CC1CC=CCC1,C1CC2OC2CC1C1CO1,4-VINYLCYCLOHEXENE,MetXBioDB Augmented
,tamoxifen,,Endoxifen O-glucuronide,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)c1ccccc1,tamoxifen,MetXBioDB Augmented
,tamoxifen,,Endoxifen O-sulfate,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,CCC(=C(c1ccc(OCCNC)cc1)c1ccc(OS(=O)(=O)O)cc1)c1ccccc1,tamoxifen,MetXBioDB Augmented
,melatonin,,,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,COc1cc2c(CCNC(C)=O)c[nH]c2cc1OC1OC(C(=O)O)C(O)C(O)C1O,melatonin,MetXBioDB Augmented
,(s)-venlafaxine,,,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,NCC(c1ccc(OC2OC(C(=O)O)C(O)C(O)C2O)cc1)C1(O)CCCCC1,(s)-venlafaxine,MetXBioDB Augmented
,codeine,,,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,CN1CCC23c4c5ccc(O)c4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,codeine,MetXBioDB Augmented
,propofol,,,CC(C)c1cccc(C(C)C)c1O,CC(C)c1cc(O)cc(C(C)C)c1OC1OC(C(=O)O)C(O)C(O)C1O,propofol,MetXBioDB Augmented
,propofol,,,CC(C)c1cccc(C(C)C)c1O,CC(C)c1cc(OS(=O)(=O)O)cc(C(C)C)c1O,propofol,MetXBioDB Augmented
,galantamine,,,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,CN1CCC23C=CC(O)CC2Oc2c(OS(=O)(=O)O)ccc(c23)C1,galantamine,MetXBioDB Augmented
,etoricoxib,,,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,CS(=O)(=O)c1ccc(-c2cc(Cl)cnc2-c2ccc(COC3OC(C(=O)O)C(O)C(O)C3O)nc2)cc1,etoricoxib,MetXBioDB Augmented
,"3,4-dihydroxyphenylacetic acid",,2-Phenylacetic acid,O=C(O)Cc1ccc(O)c(O)c1,O=C(O)Cc1ccccc1,"3,4-dihydroxyphenylacetic acid",MetXBioDB Augmented
,"3,4-dihydroxyphenylacetic acid",,2-Phenylacetic acid,O=C(O)Cc1ccc(O)c(O)c1,O=C(O)Cc1ccccc1,"3,4-dihydroxyphenylacetic acid",MetXBioDB Augmented
